Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Edwards Lifesciences Corp | ew10-kq42017.htm |
| EX-31.1 - EXHIBIT 31.1 - Edwards Lifesciences Corp | ex-31110xkq42017.htm |
| EX-10.34 - EXHIBIT 10.34 - Edwards Lifesciences Corp | ex-103410xkq42017.htm |
| EX-21.1 - EXHIBIT 21.1 - Edwards Lifesciences Corp | ex-21110xkq42017.htm |
| EX-23 - EXHIBIT 23 - Edwards Lifesciences Corp | ex-2310xkq42017.htm |
| EX-10.35 - EXHIBIT 10.35 - Edwards Lifesciences Corp | ex-103510xkq42017.htm |
| EX-10.33 - EXHIBIT 10.33 - Edwards Lifesciences Corp | ex-103310xkq42017.htm |
| EX-31.2 - EXHIBIT 31.2 - Edwards Lifesciences Corp | ex-31210xkq42017.htm |
| EX-10.27 - EXHIBIT 10.27 - Edwards Lifesciences Corp | ex-102710xkq42017.htm |
| EX-12.1 - EXHIBIT 12.1 - Edwards Lifesciences Corp | ex-12110xkq42017.htm |
Exhibit 32
EDWARDS LIFESCIENCES CORPORATION
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Edwards Lifesciences Corporation (the "Company") on Form 10-K for the year ended December 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), we, Michael A. Mussallem, Chairman of the Board and Chief Executive Officer of the Company, and Scott B. Ullem, Corporate Vice President, Chief Financial Officer, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ MICHAEL A. MUSSALLEM | ||
February 16, 2018 | Michael A. Mussallem Chairman of the Board and Chief Executive Officer | |
/s/ SCOTT B. ULLEM | ||
February 16, 2018 | Scott B. Ullem Corporate Vice President, Chief Financial Officer | |